Advertisement

Weak Proinsulin Peptide–Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in Mice

  1. Matteo G. Levisetti12,
  2. Danna M. Lewis1,
  3. Anish Suri2 and
  4. Emil R. Unanue2
  1. 1Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
  2. 2Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri
  1. Corresponding author: Matteo G. Levisetti, mleviset{at}im.wustl.edu

Abstract

OBJECTIVE—Weak major histocompatibility complex (MHC) binding of self-peptides has been proposed as a mechanism that may contribute to autoimmunity by allowing for escape of autoreactive T-cells from the thymus. We examined the relationship between the MHC-binding characteristics of a β-cell antigen epitope and T-cell autoreactivity in a model of autoimmune diabetes.

RESEARCH DESIGN AND METHODS—The binding of a proinsulin epitope, proinsulin-1(47–64) (PI-1[47–64]), to the MHC class II molecules I-Ag7 and I-Ak was measured using purified class II molecules. T-cell reactivity to the proinsulin epitope was examined in I-Ag7+ and I-Ak+ mice.

RESULTS—C-peptide epitopes bound very weakly to I-Ag7 molecules. However, C-peptide–reactive T-cells were induced after immunization in I-Ag7–bearing mice (NOD and B6.g7) but not in I-Ak–bearing mice (B10.BR and NOD.h4). T-cells reactive with the PI-1(47–64) peptide were found spontaneously in the peripancreatic lymph nodes of pre-diabetic NOD mice. These T-cells were activated by freshly isolated β-cells in the presence of antigen-presenting cells and caused diabetes when transferred into NOD.scid mice.

CONCLUSIONS—These data demonstrate an inverse relationship between self-peptide–MHC binding and T-cell autoreactivity for the PI-1(47–64) epitope in autoimmune diabetes.

Footnotes

  • Published ahead of print at http://diabetes.diabetesjournals.org on 8 April 2008.

  • Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • See accompanying commentary, p. 1788.

    • Accepted March 2, 2008.
    • Received January 1, 2008.
| Table of Contents

This Article

  1. Diabetes July 2008 vol. 57 no. 7 1852-1860
  1. » Abstract
  2. All Versions of this Article:
    1. db08-0068v1
    2. 57/7/1852 most recent

Social Bookmarking

Advertisement